HORIZONS GLOBAL SOLUTIONS LLC

Lobbying for CAPTURA BIOPHARMA · Captura is developing an orally administered MCM for radionuclide contamination.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Arkansas · House · Senate · posted Oct 8, 2025

Lobbying activity 2

Defense

FY2025/2026 NDAA; FY2025/2026 Defense Appropriations

Disaster Planning/Emergencies

FY2025/2026 NDAA; FY2025/2026 Defense Appropriations

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.